PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
Holding PMCB?
Track your performance easily

PharmaCyte Biotech (PMCB) Ownership - Who Owns PharmaCyte Biotech?

219 Followers

PharmaCyte Biotech (PMCB) Ownership Overview

4.59%1.09%2.77%91.55%
1.09% Other Institutional Investors
2.77% ETFs
91.55% Public Companies and
Individual Investors
The ownership structure of PharmaCyte Biotech (PMCB) stock is a mix of institutional, retail, and individual investors. Approximately 8.45% of the company’s stock is owned by Institutional Investors, and 91.55% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
192,387Institution2.51%334,753
192,387Institution2.51%334,753
150,309Institution1.96%261,538
20,213Institution0.26%35,171
5,947Institution0.08%10,348
2,009Institution0.03%3,496
1,804Institution0.02%3,139
2Institution<0.01%3

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
192,387Institution2.51%334,753
150,309Institution1.96%261,538
5,947Institution0.08%10,348
2,009Institution0.03%3,496
1,804Institution0.02%3,139

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
117,468Institution1.53%224,364
74,919Institution0.98%143,095
11,506Institution0.15%20,826
8,707Institution0.11%15,760

FAQ

Who Owns PharmaCyte Biotech (PMCB)?
Currently, no data Available
What percentage of PharmaCyte Biotech (PMCB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.09% of PharmaCyte Biotech (PMCB) stock is held by institutional investors.
    What percentage of PharmaCyte Biotech (PMCB) stock is held by retail investors?
    According to the latest TipRanks data, approximately 91.55% of PharmaCyte Biotech (PMCB) stock is held by retail investors.
      Who owns the most shares of PharmaCyte Biotech (PMCB)?
      Vanguard owns the most shares of PharmaCyte Biotech (PMCB).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis